239 related articles for article (PubMed ID: 35127488)
1. Genome-Wide Methylation Profiling of lncRNAs Reveals a Novel Progression-Related and Prognostic Marker for Colorectal Cancer.
Lin S; Gu S; Qian S; Liu Y; Sheng J; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Chen K; Jin M
Front Oncol; 2021; 11():782077. PubMed ID: 35127488
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis.
Qian S; Lin S; Xu X; Bai H; Yeerken A; Ying X; Li Z; Fei X; Yang J; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2022 Sep; 14(1):111. PubMed ID: 36064442
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide screening for differentially methylated long noncoding RNAs identifies LIFR-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer.
Song P; Li Y; Wang F; Pu L; Bao L; Gao H; Zhu C; Wang M; Tao L
Clin Epigenetics; 2022 Oct; 14(1):138. PubMed ID: 36316703
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
[TBL] [Abstract][Full Text] [Related]
7. Construction and Validation of a Novel Ferroptosis-Related lncRNA Signature to Predict Prognosis in Colorectal Cancer Patients.
Zhang W; Fang D; Li S; Bao X; Jiang L; Sun X
Front Genet; 2021; 12():709329. PubMed ID: 34777458
[No Abstract] [Full Text] [Related]
8. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
Chen Y; Yu X; Xu Y; Shen H
Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
[TBL] [Abstract][Full Text] [Related]
9. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA DLX6-AS1 functions as a competing endogenous RNA for miR-577 to promote malignant development of colorectal cancer.
Zhou FR; Pan ZP; Shen F; Huang LQ; Cui JH; Cai K; Guo XL
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3742-3748. PubMed ID: 31115000
[TBL] [Abstract][Full Text] [Related]
11. Expression profile analysis of two antisense lncRNAs to improve prognosis prediction of colorectal adenocarcinoma.
Shademan M; Naseri Salanghuch A; Zare K; Zahedi M; Foroughi MA; Akhavan Rezayat K; Mosannen Mozaffari H; Ghaffarzadegan K; Goshayeshi L; Dehghani H
Cancer Cell Int; 2019; 19():278. PubMed ID: 31708689
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
14. Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis.
Zhu H; Yu J; Zhu H; Guo Y; Feng S
World J Surg Oncol; 2017 Aug; 15(1):153. PubMed ID: 28797257
[TBL] [Abstract][Full Text] [Related]
15. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
[TBL] [Abstract][Full Text] [Related]
16. A genomic screen for long noncoding RNA genes epigenetically silenced by aberrant DNA methylation in colorectal cancer.
Kumegawa K; Maruyama R; Yamamoto E; Ashida M; Kitajima H; Tsuyada A; Niinuma T; Kai M; Yamano HO; Sugai T; Tokino T; Shinomura Y; Imai K; Suzuki H
Sci Rep; 2016 May; 6():26699. PubMed ID: 27215978
[TBL] [Abstract][Full Text] [Related]
17. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
Li DJ; Feng ZC; Li XR; Hu G
World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
[TBL] [Abstract][Full Text] [Related]
18. Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.
Luo R; Song J; Zhang W; Ran L
Dig Dis Sci; 2020 Dec; 65(12):3538-3550. PubMed ID: 31960204
[TBL] [Abstract][Full Text] [Related]
19. Upregulated long noncoding RNAs LINC02163 and FEZF1-AS1 exert oncogenic roles in colorectal cancer.
Tian Y; Zhou J; Zou Y; Luo B; Liu Q; Cao X
Anticancer Drugs; 2021 Jan; 32(1):66-73. PubMed ID: 32932277
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of
Lin RK; Hung WY; Huang YF; Chang YJ; Lin CH; Chen WY; Chiu SF; Chang SC; Tsai SF
Oncotarget; 2017 Dec; 8(69):113431-113443. PubMed ID: 29371920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]